查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386154

mRNA 疫苗市场报告：2030 年趋势、预测与竞争分析

mRNA Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

mRNA 疫苗的趋势和预测

到2030年，全球mRNA疫苗市场预计将达到268亿美元，2024年至2030年的年复合成长率为8.3%。该市场的主要驱动力是对新疫苗和治疗方法的需求激增以及患有慢性病和感染疾病的患者数量不断增加。全球mRNA疫苗市场前景广阔，医院/诊所市场和研究设施市场蕴藏商机。

mRNA疫苗市场洞察

Lucintel 预测，癌症免疫疗法将在预测期内达到最高成长。

在这个市场中，由于疫苗接种方便、训练有素的医务人员以及先进的医疗基础设施，患者越来越喜欢医院和诊所。医院和诊所仍然是最大的细分市场。

由于感染疾病在人口中的传播、强大的医疗基础设施以及主要企业的存在，预计北美仍将是最大的地区。我会的。

市场规模/估计： mRNA 疫苗的市场规模以金额估计（10 亿美元）。

趋势和预测分析：各个细分市场和地区的市场趋势（2018-2023）和预测（2024-2030）。

市场区隔分析：按类型、应用、最终用途和金额区域估计 mRNA 疫苗的市场规模（十亿美元）

区域分析：北美、欧洲、亚太地区和世界其他地区 mRNA 疫苗市场的区域细分。

成长机会：按 mRNA 疫苗市场类型、应用、最终用途和区域进行成长机会分析。

策略分析： mRNA疫苗市场併购、新产品开发、竞争形势等。

基于波特五力模型的产业竞争实力分析。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球mRNA疫苗市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球mRNA疫苗市场趋势（2018-2023）与预测（2024-2030）
  • 按类型分類的全球 mRNA 疫苗市场
    • 自扩增 mRNA 疫苗 (SAM)
    • 常规非扩增 mRNA 疫苗
  • 全球 mRNA 疫苗市场（依应用）
    • 癌症免疫治疗
    • 过敏耐受性
    • 治疗性疫苗
  • 全球 mRNA 疫苗市场（依最终用途）
    • 医院和诊所
    • 研究
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球mRNA疫苗市场区域分布
  • 北美mRNA疫苗市场
  • 欧洲mRNA疫苗市场
  • 亚太地区mRNA疫苗市场
  • 其他地区mRNA疫苗市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按类型分類的全球 mRNA 疫苗市场成长机会
    • 全球 mRNA 疫苗市场成长机会（按应用）
    • 全球 mRNA 疫苗市场成长机会（依最终用途）
    • 全球 mRNA 疫苗市场成长机会（按地区）
  • 全球mRNA疫苗市场的新趋势
  • 战略分析
    • 新产品开发
    • 全球 mRNA 疫苗市场产能扩张
    • 全球mRNA疫苗市场的合併、收购和合资企业
    • 认证和许可

第7章主要企业概况

  • Pfizer
  • Moderna
  • BioNTech
  • GlaxoSmithKline
  • Daiichi Sankyo
简介目录

mRNA Vaccine Trends and Forecast

The future of the global mRNA vaccine market looks promising with opportunities in the hospital & clinic and research laboratory markets. The global mRNA vaccine market is expected to reach an estimated $26.8 billion by 2030 with a CAGR of 8.3% from 2024 to 2030. The major drivers for this market are soaring demand for new vaccines and therapeutics and rising cases of chronic and infectious diseases.

A more than 150-page report is developed to help in your business decisions.

mRNA Vaccine by Segment

The study includes a forecast for the global mRNA vaccine by type, application, end use, and region.

mRNA Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Self-Amplifying mRNA Vaccines (SAM)
  • Conventional Non-Amplifying mRNA Vaccines

mRNA Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Cancer Immunotherapy
  • Allergy Tolerization
  • Therapeutic Vaccines

mRNA Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Research Laboratories
  • Others

mRNA Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of mRNA Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies mRNA vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the mRNA vaccine companies profiled in this report include-

  • Pfizer
  • Moderna
  • BioNTech
  • GlaxoSmithKline
  • Daiichi Sankyo

mRNA Vaccine Market Insights

Lucintel forecasts that cancer immunotherapy is expected to witness highest growth over the forecast period.

Within this market, hospital & clinic will remain the largest segment due to growing patients preference for this facilities because of the convenient access to vaccinations, availability of trained medical personnel, and existence of advanced healthcare infrastructure.

North America will remain the largest regiondue to augmenting prevalence of infectious diseases among population, existence of robust healthcare infrastructure, and presence of key players in the region.

Features of the Global mRNA Vaccine Market

Market Size Estimates: mRNA vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: mRNA vaccine market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: mRNA vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, end uses, and regions for the mRNA vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the mRNA vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the mRNA vaccine market size?

Answer: The global mRNA vaccine market is expected to reach an estimated $26.8 billion by 2030.

Q.2 What is the growth forecast for mRNA vaccine market?

Answer: The global mRNA vaccine market is expected to grow with a CAGR of 8.3% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the mRNA vaccine market?

Answer: The major drivers for this market are soaring demand for new vaccines and therapeutics and rising cases of chronic and infectious diseases.

Q4. What are the major segments for mRNA vaccine market?

Answer: The future of the mRNA vaccine market looks promising with opportunities in the hospital & clinic and research laboratory markets.

Q5. Who are the key mRNA vaccine market companies?

Answer: Some of the key mRNA vaccine companies are as follows:

  • Pfizer
  • Moderna
  • BioNTech
  • GlaxoSmithKline
  • Daiichi Sankyo

Q6. Which mRNA vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that cancer immunotherapy is expected to witness highest growth over the forecast period.

Q7. In mRNA vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest regiondue to augmenting prevalence of infectious diseases among population, existence of robust healthcare infrastructure, and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the mRNA vaccine market by type (self-amplifying mRNA vaccines (SAM) and conventional non-amplifying mRNA vaccines), application (cancer immunotherapy, allergy tolerization, and therapeutic vaccines), end use (hospitals & clinics, research laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global mRNA Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global mRNA Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global mRNA Vaccine Market by Type
    • 3.3.1: Self-Amplifying mRNA Vaccines (SAM)
    • 3.3.2: Conventional Non-Amplifying mRNA Vaccines
  • 3.4: Global mRNA Vaccine Market by Application
    • 3.4.1: Cancer Immunotherapy
    • 3.4.2: Allergy Tolerization
    • 3.4.3: Therapeutic Vaccines
  • 3.5: Global mRNA Vaccine Market by End Use
    • 3.5.1: Hospitals & Clinics
    • 3.5.2: Research Laboratories
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global mRNA Vaccine Market by Region
  • 4.2: North American mRNA Vaccine Market
    • 4.2.1: North American mRNA Vaccine Market by Application: Cancer Immunotherapy, Allergy Tolerization, and Therapeutic Vaccines
    • 4.2.2: North American mRNA Vaccine Market by End Use: Hospitals & Clinics, Research Laboratories, and Others
  • 4.3: European mRNA Vaccine Market
    • 4.3.1: European mRNA Vaccine Market by Application: Cancer Immunotherapy, Allergy Tolerization, and Therapeutic Vaccines
    • 4.3.2: European mRNA Vaccine Market by End Use: Hospitals & Clinics, Research Laboratories, and Others
  • 4.4: APAC mRNA Vaccine Market
    • 4.4.1: APAC mRNA Vaccine Market by Application: Cancer Immunotherapy, Allergy Tolerization, and Therapeutic Vaccines
    • 4.4.2: APAC mRNA Vaccine Market by End Use: Hospitals & Clinics, Research Laboratories, and Others
  • 4.5: ROW mRNA Vaccine Market
    • 4.5.1: ROW mRNA Vaccine Market by Application: Cancer Immunotherapy, Allergy Tolerization, and Therapeutic Vaccines
    • 4.5.2: ROW mRNA Vaccine Market by End Use: Hospitals & Clinics, Research Laboratories, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global mRNA Vaccine Market by Type
    • 6.1.2: Growth Opportunities for the Global mRNA Vaccine Market by Application
    • 6.1.3: Growth Opportunities for the Global mRNA Vaccine Market by End Use
    • 6.1.4: Growth Opportunities for the Global mRNA Vaccine Market by Region
  • 6.2: Emerging Trends in the Global mRNA Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global mRNA Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global mRNA Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Pfizer
  • 7.2: Moderna
  • 7.3: BioNTech
  • 7.4: GlaxoSmithKline
  • 7.5: Daiichi Sankyo